Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Supra Boga Lestari Tbk. (RANC) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Supra Boga Lestari Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Supra Boga Lestari Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume), while Supra Boga Lestari Tbk. trades at Rp520 (market cap 821.36B, 6.5K 24h volume). The key difference: Supra Boga Lestari Tbk. is far larger — about 2.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (124.3K versus 6.5K). Which is the better fit depends on your goals.

DGNSRANC
Market Cap
319B821.36B
Volume
124.3K6.5K
Lot
1.24K65
Turnover
28.28M3.39M
Average Price
227.48520.85
Value
28.28M3.39M
Indicative Equilibrium Price
228520
Indicative Equilibrium Volume
10010

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
RANC
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Supra Boga Lestari Tbk.

PT Supra Boga Lestari Tbk (the Company) was established in Indonesia based on Notarial Deed No. 34 of Suwarni Sukiman, S.H., dated May 28, 1997.

Read more on RANC